BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  AzurRx Carves Out Slice of IBD Market in $229 Million Buyout

  AzurRx will change its name to First Wave BioPharma, Inc., and the company’s shares will trade on the Nasdaq under the ticker symbol “FWBI.”

  September 13, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Fred Frank, ‘Founding Father’ of Biotech, Dead at 89

  Frederick Frank, an innovator of biotech investment who played a key role in Roche’s acquisition of Genentech and the merger that formed Bristol-Myers Squibb, has died.

  September 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Chinese Biopharma Strikes Deal with Western Company for COVID-19 Vaccine

  Everest will pay Providence $50 million in cash upfront for access to its COVID-19 vaccine and other mRNA vaccine candidates targeting specific variants in earlier stages of development.

  September 13, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  BeiGene’s Immuno-oncology Portfolio Running Strong in Lung Cancer

  BeiGene plans to describe the power of its lung cancer portfolio at the European Society for Medical Oncology Congress 2021. The conference will run from September 16-21.

  September 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  A Recurring COVID-19 Origin Theory and a Vaccine for Kids by Halloween?

  Dr. Scott Gottlieb estimated that a vaccine for the 5-11-year-old age group could be available by Halloween – in a best-case scenario.

  September 13, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Policy

  Inappropriate Sexual Behavior Allegations Confirmed Against Aubrey de Grey

  SENS Research Foundation released findings that confirmed the charges of inappropriate behavior raised by two former female employees against Aubrey de Grey.

  September 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Bolt’s Recent Collabs Support Goal of Pioneering New Class of Immuno-Oncology Agents

  Bolt Biotherapeutics was anything but quiet this summer.

  September 13, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Business

  Industry Veteran Rusty Williams Leads Startup to $50 Million Series A

  South San Francisco-based Walking Fish started the week off strong by announcing its closing of a $50 million Series A financing round on Monday.

  September 13, 2021

   · 

  1 min read

   · 

  Ellen Bombela
• 

  FDA

  Study: 1/3 of Cancer Accelerated Approval Indications Remain Despite Lack of Confirmation

  A recent study suggests that about one-third of cancer indications with Accelerated Approval pathways are still on product labels without follow-up studies confirming their benefits.

  September 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  AVITA’s Personalized Vaccine Kit Elicits Robust Immune Memory Response

  The Phase II study showed enhanced immune memory response to the virus in 96% of vaccinated subjects, all of whom were exposed to an environment dominated by the delta variant.

  September 13, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN